Doximity Reports $34.7 million in Latest Quarterly Results
Doximity reported quarterly results highlighted by Net income of $34.7 million, margin of 20%, according to its earnings release filed with an 8-K Thursday.
36.8%. Non-GAAP net income of $68.3 million. Adjusted EBITDA of $88.9 million, margin of 51%. Total revenues of $174.5 million, up 4% year-over-year.
Results detail
Further figures in the release included Revenue: Revenue of $174.5 million, versus $168.5 million, an increase of 4% year-over-year; Adjusted EBITDA: Adjusted EBITDA of $88.9 million, versus $100.8 million, a decrease of 12% year-over-year, representing adjusted EBITDA margins of 50.9%, versus 59.8%; Net income and non-GAAP net income: Net income of $34.7 million, versus $62.1 million, representing a margin of 19.9%, versus 36.8%. Non-GAAP net income of $68.3 million, versus $90.0 million, representing a margin of 39.1%, versus 53.4%.
The filing is an Item 2.02 results announcement furnished with Exhibit 99.1. Comparisons use the year-earlier period as presented by Doximity unless the release specifies another baseline. Where both GAAP and non-GAAP metrics appear, both are summarized when the extract includes them.
Segment mix, cash flow and any outlook language in the release are the usual secondary reads after the headline revenue and earnings figures.
Why it matters
For retail investors, the Doximity print is a check on whether growth, margins and cash generation are moving together. The figures above come from the company’s Exhibit 99.1 earnings materials; how they stack up against the prior-year run rate and any guide published with the release will shape the near-term debate.
By the numbers
- Net income of $34.7 million, margin of 20%
- 36.8%. Non-GAAP net income of $68.3 million
- Adjusted EBITDA of $88.9 million, margin of 51%
- Total revenues of $174.5 million, up 4% year-over-year
- Revenue: Revenue of $174.5 million, versus $168.5 million, an increase of 4% year-over-year.
- Adjusted EBITDA: Adjusted EBITDA of $88.9 million, versus $100.8 million, a decrease of 12% year-over-year, representing adjusted EBITDA margins of 50.9%, versus 59.8%.
Sources
- Doximity, Inc. Form 8-K with quarterly financial results, filed Nov. 5, 2026 (accession 0001516513-26-000049)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.